Metformin might curb Parkinson's risk in diabetes patients

04/16/2012 | MedicalDaily.com

Adding metformin to sulfonylurea treatment may significantly cut the increased risk of Parkinson's disease seen in patients with diabetes, according to a study in Parkinsonism and Related Disorders. "An exciting aspect of the finding is that metformin seems to be working to protect the brain against neurodegeneration, which contributes to [Parkinsonism]. This means it may also be considered a relevant therapy for the prevention of dementia as well," lead author Mark Wahlqvist said.

View Full Article in:

MedicalDaily.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations